Thought Leadership

Our leading subject matter experts share their insightful analysis and points of view to help you stay abreast of industry trends

Case Study: Using Real-Time Market Access Data to Build a Strong Commercialization Strategy

By MMIT

Developing the first and only FDA-approved treatment for a particular indication is no longer a guarantee of market access. Before the launch of its first commercial product, one small biotech company was concerned about restrictive utilization management policies. How would its sales team combat barriers to patient access?

The company identified payer coverage monitoring and ongoing analysis of payer responses as its most urgent priorities. The company selected MMIT Analytics to provide payer coverage and restriction data and MMIT Surveillance for real-time alerts about updated policies. They also used Formtrak and Coverage Search to share access details with targeted providers.

Less than a year after achieving FDA approval, the company’s product had already achieved its core launch goals. Read the full case study to learn how.

© 2025 MMIT
MMIT

MMIT

Related Posts

real-world-lab-claims-data
May 18

How Real-World Data Helps Manufacturers See the Complete Market Access Story

Read More
brown-capsule-among-many-blue-and-white-capsule-pills-for-rare-diseases
June 13

Product Launch Success: Getting It Right In Rare Disease

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today